Daiichi - Sankyo

DAIICHI SANKYO PHARMACEUTICAL(SHANGHAI)CO.,LTD was established in 1999 in the Zhangjiang High-Tech Park, Shanghai, covering an area of 50,000 square meters with a total investment of 59 million US dollars. It is a wholly-owned subsidiary of Daiichi - Sankyo, a globally renowned original research pharmaceutical group. The company is mainly engaged in the development, production, sales, and consultation of pharmaceuticals, as well as the import, export, and wholesale of pharmaceuticals. As the core of Daiichi - Sankyo's operations in China, the company tirelessly strives to fulfill the group’s corporate vision (Global Drug Innovator). It continuously introduces internationally leading products and technologies, strictly adheres to GMP requirements for production and quality control, and uses professional service awareness and dedication to accurately and promptly convey the latest clinical drug information and treatment methods to medical professionals, contributing to the improvement of patients' quality of life.